Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

328 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
13C-erythromycin breath test as a noninvasive measure of CYP3A activity in newborn infants: a pilot study.
de Wildt SN, Berns MJ, van den Anker JN. de Wildt SN, et al. Among authors: van den anker jn. Ther Drug Monit. 2007 Apr;29(2):225-30. doi: 10.1097/FTD.0b013e31803d156d. Ther Drug Monit. 2007. PMID: 17417078
Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks.
Huisman-de Boer JJ, van den Anker JN, Vogel M, Goessens WH, Schoemaker RC, de Groot R. Huisman-de Boer JJ, et al. Among authors: van den anker jn. Antimicrob Agents Chemother. 1995 Feb;39(2):431-4. doi: 10.1128/aac.39.2.431. Antimicrob Agents Chemother. 1995. PMID: 7726510 Free PMC article.
Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age.
van den Anker JN, Schoemaker RC, Hop WC, van der Heijden BJ, Weber A, Sauer PJ, Neijens HJ, de Groot R. van den Anker JN, et al. Among authors: van der heijden bj. Clin Pharmacol Ther. 1995 Dec;58(6):650-9. doi: 10.1016/0009-9236(95)90021-7. Clin Pharmacol Ther. 1995. PMID: 8529330
Once-daily versus twice-daily administration of ceftazidime in the preterm infant.
van den Anker JN, Schoemaker RC, van der Heijden BJ, Broerse HM, Neijens HJ, de Groot R. van den Anker JN, et al. Among authors: van der heijden bj. Antimicrob Agents Chemother. 1995 Sep;39(9):2048-50. doi: 10.1128/aac.39.9.2048. Antimicrob Agents Chemother. 1995. PMID: 8540714 Free PMC article. Clinical Trial.
The effect of asphyxia on the pharmacokinetics of ceftazidime in the term newborn.
Van Den Anker JN, Van Der Heijden BJ, Hop WC, Schoemaker RC, Broerse HM, Neijens HJ, De Groot R. Van Den Anker JN, et al. Among authors: van der heijden bj. Pediatr Res. 1995 Nov;38(5):808-11. doi: 10.1203/00006450-199511000-00028. Pediatr Res. 1995. PMID: 8552453
Tobramycin population pharmacokinetics in neonates.
de Hoog M, Schoemaker RC, Mouton JW, van den Anker JN. de Hoog M, et al. Among authors: van den anker jn. Clin Pharmacol Ther. 1997 Oct;62(4):392-9. doi: 10.1016/S0009-9236(97)90117-X. Clin Pharmacol Ther. 1997. PMID: 9357390
Glucuronidation in humans. Pharmacogenetic and developmental aspects.
de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. de Wildt SN, et al. Among authors: van den anker jn. Clin Pharmacokinet. 1999 Jun;36(6):439-52. doi: 10.2165/00003088-199936060-00005. Clin Pharmacokinet. 1999. PMID: 10427468 Review.
Use of saliva in therapeutic drug monitoring of caffeine in preterm infants.
de Wildt SN, Kerkvliet KT, Wezenberg MG, Ottink S, Hop WC, Vulto AG, van Den Anker JN. de Wildt SN, et al. Among authors: van den anker jn. Ther Drug Monit. 2001 Jun;23(3):250-4. doi: 10.1097/00007691-200106000-00011. Ther Drug Monit. 2001. PMID: 11360033
Pharmacokinetics and metabolism of intravenous midazolam in preterm infants.
de Wildt SN, Kearns GL, Hop WC, Murry DJ, Abdel-Rahman SM, van den Anker JN. de Wildt SN, et al. Among authors: van den anker jn. Clin Pharmacol Ther. 2001 Dec;70(6):525-31. doi: 10.1067/mcp.2001.120683. Clin Pharmacol Ther. 2001. PMID: 11753268 Clinical Trial.
Pharmacokinetics and metabolism of oral midazolam in preterm infants.
de Wildt SN, Kearns GL, Hop WC, Murry DJ, Abdel-Rahman SM, van den Anker JN. de Wildt SN, et al. Among authors: van den anker jn. Br J Clin Pharmacol. 2002 Apr;53(4):390-2. doi: 10.1046/j.1365-2125.2002.01223.x. Br J Clin Pharmacol. 2002. PMID: 11966671 Free PMC article.
328 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback